357 related articles for article (PubMed ID: 16442356)
1. Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy).
James SK; Lindahl B; Timmer JR; Ottervanger JP; Siegbahn A; Stridsberg M; Armstrong P; Califf R; Wallentin L; Simoons ML
Am J Cardiol; 2006 Jan; 97(2):167-72. PubMed ID: 16442356
[TBL] [Abstract][Full Text] [Related]
2. Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy.
James SK; Lindbäck J; Tilly J; Siegbahn A; Venge P; Armstrong P; Califf R; Simoons ML; Wallentin L; Lindahl B
J Am Coll Cardiol; 2006 Sep; 48(6):1146-54. PubMed ID: 16978997
[TBL] [Abstract][Full Text] [Related]
3. Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers.
Westerhout CM; Fu Y; Lauer MS; James S; Armstrong PW; Al-Hattab E; Califf RM; Simoons ML; Wallentin L; Boersma E;
J Am Coll Cardiol; 2006 Sep; 48(5):939-47. PubMed ID: 16949483
[TBL] [Abstract][Full Text] [Related]
4. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
James SK; Lindahl B; Siegbahn A; Stridsberg M; Venge P; Armstrong P; Barnathan ES; Califf R; Topol EJ; Simoons ML; Wallentin L
Circulation; 2003 Jul; 108(3):275-81. PubMed ID: 12847065
[TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
Heeschen C; Hamm CW; Mitrovic V; Lantelme NH; White HD;
Circulation; 2004 Nov; 110(20):3206-12. PubMed ID: 15533869
[TBL] [Abstract][Full Text] [Related]
6. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
[TBL] [Abstract][Full Text] [Related]
7. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
8. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
[TBL] [Abstract][Full Text] [Related]
9. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock.
Vergès B; Zeller M; Desgrès J; Dentan G; Laurent Y; Janin-Manificat L; L'Huillier I; Rioufol G; Beer JC; Makki H; Rochette L; Gambert P; Cottin Y
Eur Heart J; 2005 Sep; 26(17):1734-41. PubMed ID: 15831555
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention.
Verouden NJ; Haeck JD; Kuijt WJ; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; van Straalen JP; Fischer J; Piek JJ; Tijssen JG; de Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1047-52. PubMed ID: 20381651
[TBL] [Abstract][Full Text] [Related]
11. Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction.
Björklund E; Jernberg T; Johanson P; Venge P; Dellborg M; Wallentin L; Lindahl B;
Heart; 2006 Jun; 92(6):735-40. PubMed ID: 16251228
[TBL] [Abstract][Full Text] [Related]
12. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy.
Lindahl B; Lindbäck J; Jernberg T; Johnston N; Stridsberg M; Venge P; Wallentin L
J Am Coll Cardiol; 2005 Feb; 45(4):533-41. PubMed ID: 15708700
[TBL] [Abstract][Full Text] [Related]
13. N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.
Windhausen F; Hirsch A; Sanders GT; Cornel J; Fischer J; van Straalen JP; Tijssen JG; Verheugt FW; de Winter RJ;
Am Heart J; 2007 Apr; 153(4):485-92. PubMed ID: 17383283
[TBL] [Abstract][Full Text] [Related]
14. Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.
Jarai R; Fellner B; Haoula D; Jordanova N; Heinz G; Karth GD; Huber K; Geppert A
Crit Care Med; 2009 Jun; 37(6):1837-44. PubMed ID: 19384228
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome.
Wollert KC; Kempf T; Peter T; Olofsson S; James S; Johnston N; Lindahl B; Horn-Wichmann R; Brabant G; Simoons ML; Armstrong PW; Califf RM; Drexler H; Wallentin L
Circulation; 2007 Feb; 115(8):962-71. PubMed ID: 17283261
[TBL] [Abstract][Full Text] [Related]
17. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
[TBL] [Abstract][Full Text] [Related]
18. [Prognosis in unstable coronary artery disease. Multimarker strategy is the best basis for the therapeutic choice].
James S; Lindahl B; Siegbahn A; Stridsberg M; Venge P; Wallentin L
Lakartidningen; 2004 Apr; 101(17):1514-9, 1521-2. PubMed ID: 15150954
[TBL] [Abstract][Full Text] [Related]
19. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
[TBL] [Abstract][Full Text] [Related]
20. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E
J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
